Lutetium (177Lu) chloride Billev (previously Illuzyce) União Europeia - português - EMA (European Medicines Agency)

lutetium (177lu) chloride billev (previously illuzyce)

billev pharma aps - lutetium (177lu) chloride - imagem de radionuclídeos - rádiofarmacêutica terapêutica - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Sitagliptin / Metformin hydrochloride Accord União Europeia - português - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tipo 2 - drogas usadas em diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. triplo terapia de combinação), como adjuvante da dieta e exercício em pacientes inadequadamente controlados em sua máxima tolerada, a dose de metformina e uma sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

CLORIDRATO DE PROPANOLOL + HIDROCLOROTIAZIDA Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

cloridrato de propanolol + hidroclorotiazida

ems sigma pharma ltda - cloridrato de propranolol, hidroclorotiazida - anti-hipertensivos-associacoes medicamentosas

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) União Europeia - português - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 para dados disponíveis em diferentes combinações).

Methylthioninium chloride Proveblue União Europeia - português - EMA (European Medicines Agency)

methylthioninium chloride proveblue

provepharm sas - cloreto de metiltionínio - methemoglobinemia - todos os outros produtos terapêuticos - tratamento sintomático agudo de metabemoglobinemia induzida por produtos medicinais e químicos. methylthioninium cloreto de proveblue é indicado em adultos, crianças e adolescentes (0 a 17 anos de idade).

Lumeblue (previously known as Methylthioninium chloride Cosmo) União Europeia - português - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - cloreto de metiltionínio - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Sapropterin Dipharma União Europeia - português - EMA (European Medicines Agency)

sapropterin dipharma

dipharma arzneimittel gmbh - sapropterin dihydrochloride - fenilcetonurias - outro aparelho digestivo e metabolismo produtos, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

TENADREN Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

tenadren

ems sigma pharma ltda - cloridrato de propranolol, hidroclorotiazida - anti-hipertensivos-associacoes medicamentosas

TENADREN Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

tenadren

ems sigma pharma ltda - cloridrato de propranolol, hidroclorotiazida - anti-hipertensivos-associacoes medicamentosas

cloridrato de propranolol + hidroclorotiazida Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

cloridrato de propranolol + hidroclorotiazida

germed farmaceutica ltda - cloridrato de propranolol, hidroclorotiazida - anti-hipertensivos-associacoes medicamentosas